![A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children - Clinical Therapeutics A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children - Clinical Therapeutics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2e4a0d89-1a60-46b4-bf84-543523f9aa65/gr1.jpg)
A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children - Clinical Therapeutics
![Wanted: Adult ADHD Patients for a Clinical Trial to Evaluate an Investigational Medicine – ADDA – Attention Deficit Disorder Association Wanted: Adult ADHD Patients for a Clinical Trial to Evaluate an Investigational Medicine – ADDA – Attention Deficit Disorder Association](https://web.add.org/wp-content/uploads/2015/12/13183959/ALCOBRAFB2v03-e1449507247191.jpg)
Wanted: Adult ADHD Patients for a Clinical Trial to Evaluate an Investigational Medicine – ADDA – Attention Deficit Disorder Association
![A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial - The Lancet Digital Health A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial - The Lancet Digital Health](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/cb5704da-3b50-4f12-b83b-1a4fa653c119/gr1.gif)
A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial - The Lancet Digital Health
![A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder - Biological Psychiatry A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder - Biological Psychiatry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/800656/5844561/gr1.jpg)
A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder - Biological Psychiatry
![Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials | The BMJ Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials | The BMJ](https://www.bmj.com/content/bmj/351/bmj.h5203/F1.large.jpg)
Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials | The BMJ
PLOS ONE: Gastrointestinal adverse events during methylphenidate treatment of children and adolescents with attention deficit hyperactivity disorder: A systematic review with meta-analysis and Trial Sequential Analysis of randomised clinical trials
![Druggable genome in attention deficit/hyperactivity disorder and its co-morbid conditions. New avenues for treatment | Molecular Psychiatry Druggable genome in attention deficit/hyperactivity disorder and its co-morbid conditions. New avenues for treatment | Molecular Psychiatry](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41380-019-0540-z/MediaObjects/41380_2019_540_Fig1_HTML.png)
Druggable genome in attention deficit/hyperactivity disorder and its co-morbid conditions. New avenues for treatment | Molecular Psychiatry
![Vitamin-mineral treatment of attention-deficit hyperactivity disorder in adults: double-blind randomized placebo-controlled trial – Micronutrients Research Vitamin-mineral treatment of attention-deficit hyperactivity disorder in adults: double-blind randomized placebo-controlled trial – Micronutrients Research](https://micronutrientsresearch.com/wp-content/uploads/2019/06/Vitamin-mineral-treatment-of-attention-deficit-hyperactivity-disorder-in-adults-double-blind-randomised-placebo-controlled-trial.png)